Clinical Decision Support Systems Market is valued at USD 12.8 Billion in 2020 and is expected to reach USD 24.76 Billion by 2027 with a CAGR of 10.80% over the forecast period.
Global Clinical Decision Support Systems Market: Global Size, Trends, Competitive, Historical &Forecast Analysis, 2021-2027– Rising adoption of information systems and cloud computing in the healthcare industry are expected to boost the growth of the clinical decision support systems market over the forecast period.
Clinical decision support system (CDSS) is a health information technology system that is designed to provide physicians and other health professionals with clinical decision support (CDS). The Clinical decision support systems link health interpretation with health knowledge to influence health choices by clinicians for improved health care. These CDSSs constitute a major topic in artificial intelligence in medicine. The CDSS is designed with an intention to improve care quality, avoid adverse events, and aids the care team members to be more efficient. As the volume of available data is increasing the clinical decision support system has become an essential tool for healthcare providers.
Global clinical decision support systems market report is segmented on the basis of product type, component, application, and by regional & country level. Based on product type, global clinical decision support systems market is classified as the Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS and Integrated CDSS with CPOE & E.H.R. Based upon component, global clinical decision support systems market is classified into hardware, software and services. Based upon application, global clinical decision support systems market is classified into drug-drug interactions, drug allergy alerts, clinical reminders, clinical guidelines, drug dosing support and others.
By Product Type
The regions covered in this clinical decision support systems market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Some major key players in the global clinical decision support systems market are
April 13, 2017: - NextGen Healthcare has signed a deal to acquire Entrada for more than $30 million. According to the announcement, Entrada made a net gain of nearly 10 million in revenue in the 2016 calendar year. Based in Nashville, Entrada is a cloud-based solutions provider specializing in delivering mobile apps capable of integrating with multiple clinical platforms and EHR systems. Entrada helps healthcare organizations optimize existing technology investments and improve physician productivity. Moreover, the Mobile health solutions in the palm of the provider are quickly becoming some of the most valuable real estate in healthcare said President and CEO of NextGen Healthcare Rusty Frantz. These intend to invest in expanding Entrada’s capabilities, continuing to provide enhancements to their already impressive platform. Hence, the acquisition will improve physician satisfaction by providing a better caregiver and patient experience, while enabling clients to improve financial outcomes. According to the announcement, Entrada made a net gain of nearly $10 million in revenue in 2016.
Increasing importance of data-driven technologies in the healthcare sector is supporting the growth of the CDSS market worldwide. Furthermore, the increasing number of hospitals and healthcare facilities and rising adoption of clinical decision support systems are expected to boost growth of this market in the near future. According to the World Health Organization (WHO), the prevalence of chronic diseases cancer and diabetes has been tremendously increased annually in 2020, the largest number of chronic diseases sufferers in the world is around 114 million and 69 million.
However, high investment costs and lack of interoperability are major factors expected to restrain growth of the global market over the forecast period. Conversely, the healthcare reforms convert to a fee-for-value or bundled payments system, CDS will become much more attractive for cost cutting, quality improvement and meeting CMS reimbursement strategy. Med Current is one of those third-party vendors offering a package of CDS linked with analytics, order entry and an electronic rules set based on the American College of Radiology (ACR). It is also adding rule sets from the American College of Cardiology (ACC) to aid CDS software with imaging orders. Here, the clinical decision supports propose their best practices for healthcare provider organizations to optimize the technology so that physicians and other clinicians get the most out of this key health IT investment.
|Historical data||2015 - 2020|
|Forecast Period||2021 - 2027|
|Market Size in 2020:||USD 12.8 Billion|
|Base year considered||2020|
|Forecast Period CAGR %:||10.80 %|
|Market Size Expected in 2027:||USD 24.76 Billion|
|Tables, Charts & Figures:||175|
|Key Players/Companies||Agfa Healthcare, McKesson Corporation, NextGen Healthcare Information Systems, Medical Information Technology Inc., Care stream Health Inc., Athenahealth, Wolters Kluwer NU, Cerner Corporation, Siemens Healthineers and others|
|Segments Covered||By Product Type, By Component, By Application|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
Geographically, North America is expected to dominate the clinical decision support systems market during forecast period, owing to increasing demand for healthcare information technology solutions in the medical sector, technological advancements in various countries in this region. Technologically advanced research and treatment platforms for diagnosis of chronic diseases and the increase in the group medical practices in this region will fuel the clinical decision support systems market in the North America region.
According to the World Health Organization (WHO),it is estimated that big data analytics can enable more than $300 billion in savings per year in U.S. healthcare. The clinical corporation and R & D are the largest areas for potential savings with 165 billion and 108 billion. Also, Asia Pacific region is at second position in dominance. This is due to increasing government investments in healthcare sector and improved healthcare infrastructure in countries such as China, India. Rising number of collaborations and partnerships by healthcare IT providers, increasing number of mergers and acquisitions and new products launches are some of the trends that have been observed in the clinical decision support systems market.
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
Kemp House, 152 - 160 City Road, London EC1V 2NX
© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®